NBIX
$143.18+1.76%
as of close, Oct 2, 2026
☾ AH $143.18 +1.76%
Neurocrine Biosciences Inc.Stock · Health CareNasdaq Composite 0.03%Russell 1000 0.02%US Stock Market 0.02%Russell 3000 0.02%MSCI World 0.02%MSCI ACWI 0.02%
NBIX SEC filings (2026)
CIK 914475 · Biological Products, (No Diagnostic Substances) (SIC 2836) · incorporated in DE · fiscal year ends in December
2,175 filings on EDGAR since 1996 · 33 annual, 92 quarterly, 288 current · financial statements · earnings
Latest 10-K
Feb 11, 2026
fiscal year to Dec 31, 2025
Latest 10-Q
Jul 31, 2026
quarter to Jun 30, 2026
Latest 8-K
Sep 28, 2026
Directors or officers; compensation
Last earnings release
Jul 30, 2026
$2.36 vs $1.88 · ▼ 10.1%
Filings on file
2,175
since 1996, 1,399 insider forms
What happened, last 12 months#
Every earnings release with its print, every report with its quarter, the other 8-Ks by what they covered, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.
September 2026
- Sep 288-K8-K · Directors or officers; compensation
- Sep 14Insider saleABERNETHY MATT (Chief Financial Officer) sold 2,311 shares for $363K at $157.20 under a 10b5-1 plan
- Sep 14Insider saleBoyer David W. (Chief Corp. Affairs Officer) sold 826 shares for $130K at $157.45 under a 10b5-1 plan
- Sep 9Insider saleBENEVICH ERIC (Chief Commercial Officer) sold 2,154 shares for $333K at $154.61 under a 10b5-1 plan
July 2026
- Jul 31ReportQuarterly report, Q2 2026 — revenue $959.0M (+39% y/y), net income $144.4M, EPS $1.39
- Jul 318-K8-K · Financial statements and exhibits
- Jul 30EarningsEarnings release — EPS $2.36 vs $1.88 est. (+25.5%); revenue $959.0M (+39% y/y) 10.1%
- Jul 28Insider saleNorwalk Leslie V (Director) sold 1,250 shares for $228K at $182.01 under a 10b5-1 plan
- Jul 10Insider saleDelaet Ingrid (Chief Regulatory Officer) sold 4,367 shares for $791K at $181.02 under a 10b5-1 plan
- Jul 9Insider saleLippoldt Darin (Chief Legal Officer) sold 10,000 shares for $1.8M at $179.60 under a 10b5-1 plan
- Jul 9Insider saleDelaet Ingrid (Chief Regulatory Officer) sold 8,433 shares for $1.5M at $178.72 under a 10b5-1 plan
- Jul 8Insider saleDelaet Ingrid (Chief Regulatory Officer) sold 2,737 shares for $489K at $178.54 under a 10b5-1 plan
- Jul 7Insider saleDelaet Ingrid (Chief Regulatory Officer) sold 3,401 shares for $607K at $178.57 under a 10b5-1 plan
June 2026
- Jun 29Insider saleLippoldt Darin (Chief Legal Officer) sold 9,800 shares for $1.7M at $170.03–$170.81 under a 10b5-1 plan
- Jun 26Insider saleLippoldt Darin (Chief Legal Officer) sold 200 shares for $34K at $169.57 under a 10b5-1 plan
- Jun 5Insider saleSHERWIN STEPHEN A (Director) sold 25,000 shares for $4.1M at $163.81–$167.31 under a 10b5-1 plan
- Jun 4Insider saleNorwalk Leslie V (Director) sold 1,250 shares for $210K at $168.06 under a 10b5-1 plan
- Jun 2Insider saleCooke Julie (Chief Human Resources Officer) sold 36,937 shares for $5.8M at $154.83–$158.59 under a 10b5-1 plan
- Jun 1Insider saleOnyia Jude (Chief Scientific Officer) sold 11,000 shares for $1.8M at $160.25 under a 10b5-1 plan
May 2026
- May 29Insider saleDelaet Ingrid (Chief Regulatory Officer) sold 2,261 shares for $354K at $156.71 under a 10b5-1 plan
- May 288-K8-K · Directors or officers; compensation; Shareholder vote results
- May 27Insider saleOnyia Jude (Chief Scientific Officer) sold 11,000 shares for $1.7M at $155.53 under a 10b5-1 plan
- May 26Insider saleBoyer David W. (Chief Corp. Affairs Officer) sold 3,888 shares for $609K at $156.64 under a 10b5-1 plan
- May 19Insider saleGORMAN KEVIN CHARLES (Director) sold 245,088 shares for $37.8M at $154.33 under a 10b5-1 plan
- May 188-K8-K · Material definitive agreement; Completion of an acquisition or disposition; New financial obligation; Regulation FD disclosure
- May 15Insider salePOPS RICHARD F (Director) sold 15,000 shares for $2.4M at $157.65 under a 10b5-1 plan
- May 12Insider saleNorwalk Leslie V (Director) sold 3,810 shares for $591K at $155.01 under a 10b5-1 plan
- May 5EarningsEarnings release — EPS $1.41 vs $1.28 est. (+10.2%); revenue $814.5M (+42% y/y) 8.9%
- May 5ReportQuarterly report, Q1 2026 — revenue $814.5M (+42% y/y), net income $197.9M, EPS $1.91
April 2026
- Apr 15ProxyProxy · Annual report to shareholders
- Apr 15ProxyProxy · Additional proxy materials
- Apr 15ProxyProxy · Proxy statement
- Apr 68-K8-K · Material definitive agreement
February 2026
January 2026
November 2025
- Nov 248-K8-K · Directors or officers; compensation
October 2025
Insider transactions#
What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.
Over the last 13 months insiders sold $68.1M in 22 sales and bought nothing on the open market; 203 other transactions (awards, exercises, tax withholding, gifts and plan purchases).
| Date | Insider |
|---|---|
| Sep 14, 2026Form 4 | ABERNETHY MATTChief Financial OfficerSold · $363K · 2,311 sh · 10b5-1 |
| Sep 14, 2026Form 4 | Boyer David W.Chief Corp. Affairs OfficerSold · $130K · 826 sh · 10b5-1 |
| Sep 9, 2026Form 4 | BENEVICH ERICChief Commercial OfficerSold · $333K · 2,154 sh · 10b5-1 |
| Jul 28, 2026Form 4 | Norwalk Leslie VDirectorSold · $228K · 1,250 sh · 10b5-1 |
| Jul 10, 2026Form 4 | Delaet IngridChief Regulatory OfficerSold · $791K · 4,367 sh · 10b5-1 |
| Jul 9, 2026Form 4 | Lippoldt DarinChief Legal OfficerSold · $1.8M · 10,000 sh · 10b5-1 |
| Jul 9, 2026Form 4 | Delaet IngridChief Regulatory OfficerSold · $1.5M · 8,433 sh · 10b5-1 |
| Jul 8, 2026Form 4 | Delaet IngridChief Regulatory OfficerSold · $489K · 2,737 sh · 10b5-1 |
| Jul 7, 2026Form 4 | Delaet IngridChief Regulatory OfficerSold · $607K · 3,401 sh · 10b5-1 |
| Jun 29, 2026Form 4 | Lippoldt DarinChief Legal OfficerSold · $1.7M · 9,800 sh · 10b5-1 |
| Jun 26, 2026Form 4 | Lippoldt DarinChief Legal OfficerSold · $34K · 200 sh · 10b5-1 |
| Jun 5, 2026Form 4 | SHERWIN STEPHEN ADirectorSold · $4.1M · 25,000 sh · 10b5-1 |
| Jun 4, 2026Form 4 | Norwalk Leslie VDirectorSold · $210K · 1,250 sh · 10b5-1 |
| Jun 2, 2026Form 4 | Cooke JulieChief Human Resources OfficerSold · $5.8M · 36,937 sh · 10b5-1 |
| Jun 1, 2026Form 4 | Onyia JudeChief Scientific OfficerSold · $1.8M · 11,000 sh · 10b5-1 |
| May 29, 2026Form 4 | Delaet IngridChief Regulatory OfficerSold · $354K · 2,261 sh · 10b5-1 |
| May 27, 2026Form 4 | Onyia JudeChief Scientific OfficerSold · $1.7M · 11,000 sh · 10b5-1 |
| May 26, 2026Form 4 | Boyer David W.Chief Corp. Affairs OfficerSold · $609K · 3,888 sh · 10b5-1 |
| May 19, 2026Form 4 | GORMAN KEVIN CHARLESDirectorSold · $37.8M · 245,088 sh · 10b5-1 |
| May 15, 2026Form 4 | POPS RICHARD FDirectorSold · $2.4M · 15,000 sh · 10b5-1 |
| May 12, 2026Form 4 | Norwalk Leslie VDirectorSold · $591K · 3,810 sh · 10b5-1 |
| Jan 16, 2026Form 4 | Gano KyleChief Executive Officer · DirectorSold · $4.8M · 36,400 sh · 10b5-1 |
Awards, exercises, withholding and plan purchases · 203 transactions
| Date | Insider |
|---|---|
| Sep 11, 2026Form 4 | GORMAN KEVIN CHARLESDirectorTax withholding · $1.2M · 7,839 sh |
| Sep 11, 2026Form 4 | Gano KyleChief Executive Officer · DirectorTax withholding · $684K · 4,380 sh |
| Sep 11, 2026Form 4 | BENEVICH ERICChief Commercial OfficerTax withholding · $529K · 3,386 sh |
| Sep 11, 2026Form 4 | ABERNETHY MATTChief Financial OfficerTax withholding · $423K · 2,709 sh · 10b5-1 |
| Sep 11, 2026Form 4 | Lippoldt DarinChief Legal OfficerTax withholding · $378K · 2,419 sh |
| Sep 11, 2026Form 4 | Delaet IngridChief Regulatory OfficerTax withholding · $378K · 2,419 sh |
| Sep 11, 2026Form 4 | Keswani Sanjay ChandruChief Medical OfficerTax withholding · $330K · 2,112 sh |
| Sep 11, 2026Form 4 | Cooke JulieChief Human Resources OfficerTax withholding · $302K · 1,936 sh |
| Sep 11, 2026Form 4 | Onyia JudeChief Scientific OfficerTax withholding · $302K · 1,936 sh |
| Sep 11, 2026Form 4 | Boyer David W.Chief Corp. Affairs OfficerTax withholding · $302K · 1,936 sh · 10b5-1 |
| Sep 11, 2026Form 4 | GORMAN KEVIN CHARLESDirectorAward · $0 · 14,343 sh |
| Sep 11, 2026Form 4 | Gano KyleChief Executive Officer · DirectorAward · $0 · 8,117 sh |
| Sep 11, 2026Form 4 | BENEVICH ERICChief Commercial OfficerAward · $0 · 6,275 sh |
| Sep 11, 2026Form 4 | ABERNETHY MATTChief Financial OfficerAward · $0 · 5,020 sh · 10b5-1 |
| Sep 11, 2026Form 4 | Lippoldt DarinChief Legal OfficerAward · $0 · 4,483 sh |
| Sep 11, 2026Form 4 | Delaet IngridChief Regulatory OfficerAward · $0 · 4,483 sh |
| Sep 11, 2026Form 4 | Keswani Sanjay ChandruChief Medical OfficerAward · $0 · 3,914 sh |
| Sep 11, 2026Form 4 | Cooke JulieChief Human Resources OfficerAward · $0 · 3,587 sh |
| Sep 11, 2026Form 4 | Onyia JudeChief Scientific OfficerAward · $0 · 3,587 sh |
| Sep 11, 2026Form 4 | Boyer David W.Chief Corp. Affairs OfficerAward · $0 · 3,587 sh · 10b5-1 |
| Sep 9, 2026Form 4 | BENEVICH ERICChief Commercial OfficerExercise or conversion · $138K · 3,194 sh · 10b5-1 |
| Sep 9, 2026Form 4 | BENEVICH ERICChief Commercial OfficerExercise or conversion · Incentive Stock Option · $0 · 3,194 sh · 10b5-1 |
| Sep 2, 2026Form 4 | SHERWIN STEPHEN ADirectorGift · $0 · 1,000 sh |
| Aug 4, 2026Form 4 | Onyia JudeChief Scientific OfficerGift · $0 · 2,409 sh |
| Jul 29, 2026Form 4 | Norwalk Leslie VDirectorExercise or conversion · $117K · 842 sh · 10b5-1 |
| Jul 29, 2026Form 4 | Norwalk Leslie VDirectorExercise or conversion · Non-Qualified Stock Option · $0 · 842 sh · 10b5-1 |
| Jul 10, 2026Form 4 | Delaet IngridChief Regulatory OfficerExercise or conversion · $463K · 4,367 sh · 10b5-1 |
| Jul 10, 2026Form 4 | Delaet IngridChief Regulatory OfficerExercise or conversion · Non-Qualified Stock Option · $0 · 4,367 sh · 10b5-1 |
| Jul 9, 2026Form 4 | Delaet IngridChief Regulatory OfficerExercise or conversion · $873K · 8,433 sh · 10b5-1 |
| Jul 9, 2026Form 4 | Lippoldt DarinChief Legal OfficerExercise or conversion · $815K · 10,000 sh · 10b5-1 |
| Jul 9, 2026Form 4 | Lippoldt DarinChief Legal OfficerExercise or conversion · Non-Qualified Stock Option · $0 · 10,000 sh · 10b5-1 |
| Jul 9, 2026Form 4 | Delaet IngridChief Regulatory OfficerExercise or conversion · Non-Qualified Stock Option · $0 · 8,433 sh · 10b5-1 |
| Jul 8, 2026Form 4 | Delaet IngridChief Regulatory OfficerExercise or conversion · $283K · 2,737 sh · 10b5-1 |
| Jul 8, 2026Form 4 | Delaet IngridChief Regulatory OfficerExercise or conversion · Non-Qualified Stock Option · $0 · 2,737 sh · 10b5-1 |
| Jul 7, 2026Form 4 | Delaet IngridChief Regulatory OfficerExercise or conversion · $352K · 3,401 sh · 10b5-1 |
| Jul 7, 2026Form 4 | Delaet IngridChief Regulatory OfficerExercise or conversion · Non-Qualified Stock Option · $0 · 3,401 sh · 10b5-1 |
| Jun 29, 2026Form 4 | Lippoldt DarinChief Legal OfficerExercise or conversion · $799K · 9,800 sh · 10b5-1 |
| Jun 29, 2026Form 4 | Lippoldt DarinChief Legal OfficerExercise or conversion · Non-Qualified Stock Option · $0 · 9,800 sh · 10b5-1 |
| Jun 26, 2026Form 4 | Lippoldt DarinChief Legal OfficerExercise or conversion · $16K · 200 sh · 10b5-1 |
| Jun 26, 2026Form 4 | Lippoldt DarinChief Legal OfficerExercise or conversion · Non-Qualified Stock Option · $0 · 200 sh · 10b5-1 |
| Jun 5, 2026Form 4 | SHERWIN STEPHEN ADirectorExercise or conversion · $1.6M · 25,000 sh · 10b5-1 |
| Jun 5, 2026Form 4 | SHERWIN STEPHEN ADirectorExercise or conversion · Non-Qualified Stock Option · $0 · 25,000 sh · 10b5-1 |
| Jun 5, 2026Form 4 | Onyia JudeChief Scientific OfficerGift · $0 · 2,441 sh |
| Jun 2, 2026Form 4 | Cooke JulieChief Human Resources OfficerExercise or conversion · $2.0M · 24,965 sh · 10b5-1 |
| Jun 2, 2026Form 4 | Keswani Sanjay ChandruChief Medical OfficerTax withholding · $268K · 1,733 sh |
| Jun 2, 2026Form 4 | Cooke JulieChief Human Resources OfficerExercise or conversion · Non-Qualified Stock Option · $0 · 24,965 sh · 10b5-1 |
| Jun 2, 2026Form 4 | Keswani Sanjay ChandruChief Medical OfficerExercise or conversion · $0 · 3,212 sh |
| Jun 2, 2026Form 4 | Keswani Sanjay ChandruChief Medical OfficerExercise or conversion · Restricted Stock Unit · $0 · 3,212 sh |
| Jun 1, 2026Form 4 | Onyia JudeChief Scientific OfficerExercise or conversion · $932K · 11,000 sh · 10b5-1 |
| Jun 1, 2026Form 4 | Onyia JudeChief Scientific OfficerExercise or conversion · Non-Qualified Stock Option · $0 · 11,000 sh · 10b5-1 |
| May 29, 2026Form 4 | Delaet IngridChief Regulatory OfficerExercise or conversion · $179K · 2,261 sh · 10b5-1 |
| May 29, 2026Form 4 | Delaet IngridChief Regulatory OfficerExercise or conversion · Non-Qualified Stock Option · $0 · 2,261 sh · 10b5-1 |
| May 27, 2026Form 4 | Onyia JudeChief Scientific OfficerExercise or conversion · $932K · 11,000 sh · 10b5-1 |
| May 27, 2026Form 4 | Onyia JudeChief Scientific OfficerExercise or conversion · Non-Qualified Stock Option · $0 · 11,000 sh · 10b5-1 |
| May 27, 2026Form 4 | GORMAN KEVIN CHARLESDirectorAward · Non-Qualified Stock Option · $0 · 5,248 sh |
| May 27, 2026Form 4 | LYONS GARY ADirectorAward · Non-Qualified Stock Option · $0 · 2,624 sh |
| May 27, 2026Form 4 | Norwalk Leslie VDirectorAward · Non-Qualified Stock Option · $0 · 2,624 sh |
| May 27, 2026Form 4 | MORROW GEORGE JDirectorAward · Restriced Stock Unit · $0 · 2,567 sh |
| May 27, 2026Form 4 | SHERWIN STEPHEN ADirectorAward · Restriced Stock Unit · $0 · 2,567 sh |
| May 27, 2026Form 4 | POPS RICHARD FDirectorAward · Restriced Stock Unit · $0 · 2,567 sh |
| May 27, 2026Form 4 | POON CHRISTINE ADirectorAward · Restriced Stock Unit · $0 · 2,567 sh |
| May 27, 2026Form 4 | RASTETTER WILLIAM HDirectorAward · Restriced Stock Unit · $0 · 2,567 sh |
| May 27, 2026Form 4 | Sharp ShaliniDirectorAward · Restriced Stock Unit · $0 · 2,567 sh |
| May 27, 2026Form 4 | Mercier JohannaDirectorAward · Restriced Stock Unit · $0 · 2,567 sh |
| May 27, 2026Form 4 | LYONS GARY ADirectorAward · Restriced Stock Unit · $0 · 1,284 sh |
| May 27, 2026Form 4 | Norwalk Leslie VDirectorAward · Restriced Stock Unit · $0 · 1,284 sh |
| May 21, 2026Form 4 | MORROW GEORGE JDirectorExercise or conversion · $0 · 3,318 sh |
| May 21, 2026Form 4 | MORROW GEORGE JDirectorExercise or conversion · Restricted Stock Unit · $0 · 3,318 sh |
| May 21, 2026Form 4 | SHERWIN STEPHEN ADirectorExercise or conversion · $0 · 3,318 sh |
| May 21, 2026Form 4 | SHERWIN STEPHEN ADirectorExercise or conversion · Restricted Stock Unit · $0 · 3,318 sh |
| May 21, 2026Form 4 | POPS RICHARD FDirectorExercise or conversion · $0 · 3,318 sh |
| May 21, 2026Form 4 | POPS RICHARD FDirectorExercise or conversion · Restricted Stock Unit · $0 · 3,318 sh |
| May 21, 2026Form 4 | POON CHRISTINE ADirectorExercise or conversion · $0 · 3,318 sh |
| May 21, 2026Form 4 | POON CHRISTINE ADirectorExercise or conversion · Restricted Stock Unit · $0 · 3,318 sh |
| May 21, 2026Form 4 | RASTETTER WILLIAM HDirectorExercise or conversion · $0 · 3,318 sh |
| May 21, 2026Form 4 | RASTETTER WILLIAM HDirectorExercise or conversion · Restricted Stock Unit · $0 · 3,318 sh |
| May 21, 2026Form 4 | Mercier JohannaDirectorExercise or conversion · $0 · 3,318 sh |
| May 21, 2026Form 4 | Mercier JohannaDirectorExercise or conversion · Restricted Stock Unit · $0 · 3,318 sh |
| May 21, 2026Form 4 | LYONS GARY ADirectorExercise or conversion · $0 · 1,659 sh |
| May 21, 2026Form 4 | LYONS GARY ADirectorExercise or conversion · Restricted Stock Unit · $0 · 1,659 sh |
| May 21, 2026Form 4 | Sharp ShaliniDirectorExercise or conversion · $0 · 1,659 sh |
| May 21, 2026Form 4 | Sharp ShaliniDirectorExercise or conversion · Restricted Stock Unit · $0 · 1,659 sh |
| May 21, 2026Form 4 | Norwalk Leslie VDirectorExercise or conversion · $0 · 1,659 sh |
| May 21, 2026Form 4 | Norwalk Leslie VDirectorExercise or conversion · Restricted Stock Unit · $0 · 1,659 sh |
| May 19, 2026Form 4 | GORMAN KEVIN CHARLESDirectorExercise or conversion · $8.9M · 205,088 sh · 10b5-1 |
| May 19, 2026Form 4 | GORMAN KEVIN CHARLESDirectorExercise or conversion · Non-Qualified Stock Option · $0 · 205,088 sh · 10b5-1 |
| May 15, 2026Form 4 | POPS RICHARD FDirectorExercise or conversion · $718K · 15,000 sh · 10b5-1 |
| May 15, 2026Form 4 | POPS RICHARD FDirectorExercise or conversion · Non-Qualified Stock Option · $0 · 15,000 sh · 10b5-1 |
| Mar 4, 2026Form 4 | ABERNETHY MATTChief Financial OfficerGift · $0 · 2,249 sh |
| Feb 20, 2026Form 4 | Onyia JudeChief Scientific OfficerGift · $0 · 3,110 sh |
| Feb 13, 2026Form 4 | GORMAN KEVIN CHARLESDirectorTax withholding · $5.0M · 40,305 sh |
| Feb 13, 2026Form 4 | Onyia JudeChief Scientific OfficerTax withholding · $1.7M · 13,673 sh |
| Feb 13, 2026Form 4 | Delaet IngridChief Regulatory OfficerTax withholding · $1.5M · 12,245 sh |
| Feb 13, 2026Form 4 | BENEVICH ERICChief Commercial OfficerTax withholding · $1.4M · 11,145 sh |
| Feb 13, 2026Form 4 | Gano KyleChief Executive Officer · DirectorTax withholding · $990K · 7,973 sh |
| Feb 13, 2026Form 4 | ABERNETHY MATTChief Financial OfficerTax withholding · $990K · 7,973 sh |
| Feb 13, 2026Form 4 | Lippoldt DarinChief Legal OfficerTax withholding · $942K · 7,591 sh |
| Feb 13, 2026Form 4 | Boyer David W.Chief Corp. Affairs OfficerTax withholding · $892K · 7,188 sh |
| Feb 13, 2026Form 4 | Cooke JulieChief Human Resources OfficerTax withholding · $863K · 6,949 sh |
| Feb 13, 2026Form 4 | Gano KyleChief Executive Officer · DirectorAward · Stock Option · $0 · 114,830 sh |
| Feb 13, 2026Form 4 | GORMAN KEVIN CHARLESDirectorAward · $0 · 63,724 sh |
| Feb 13, 2026Form 4 | Onyia JudeChief Scientific OfficerAward · Stock Option · $0 · 55,119 sh |
| Feb 13, 2026Form 4 | ABERNETHY MATTChief Financial OfficerAward · Stock Option · $0 · 44,095 sh |
| Feb 13, 2026Form 4 | BENEVICH ERICChief Commercial OfficerAward · Stock Option · $0 · 36,287 sh |
| Feb 13, 2026Form 4 | Keswani Sanjay ChandruChief Medical OfficerAward · Stock Option · $0 · 35,827 sh |
| Feb 13, 2026Form 4 | Lippoldt DarinChief Legal OfficerAward · Stock Option · $0 · 34,909 sh |
| Feb 13, 2026Form 4 | Boyer David W.Chief Corp. Affairs OfficerAward · Stock Option · $0 · 31,234 sh |
| Feb 13, 2026Form 4 | Delaet IngridChief Regulatory OfficerAward · Stock Option · $0 · 31,234 sh |
| Feb 13, 2026Form 4 | Cooke JulieChief Human Resources OfficerAward · Stock Option · $0 · 27,100 sh |
| Feb 13, 2026Form 4 | Gano KyleChief Executive Officer · DirectorAward · Restricted Stock Unit · $0 · 20,142 sh |
| Feb 13, 2026Form 4 | Onyia JudeChief Scientific OfficerAward · $0 · 19,935 sh |
| Feb 13, 2026Form 4 | Delaet IngridChief Regulatory OfficerAward · $0 · 19,935 sh |
| Feb 13, 2026Form 4 | BENEVICH ERICChief Commercial OfficerAward · $0 · 16,613 sh |
| Feb 13, 2026Form 4 | GORMAN KEVIN CHARLESDirectorExercise or conversion · $0 · 10,981 sh |
| Feb 13, 2026Form 4 | GORMAN KEVIN CHARLESDirectorExercise or conversion · Restricted Stock Unit · $0 · 10,981 sh |
| Feb 13, 2026Form 4 | Lippoldt DarinChief Legal OfficerAward · $0 · 9,968 sh |
| Feb 13, 2026Form 4 | Gano KyleChief Executive Officer · DirectorAward · $0 · 9,968 sh |
| Feb 13, 2026Form 4 | ABERNETHY MATTChief Financial OfficerAward · $0 · 9,968 sh |
| Feb 13, 2026Form 4 | Cooke JulieChief Human Resources OfficerAward · $0 · 9,968 sh |
| Feb 13, 2026Form 4 | Boyer David W.Chief Corp. Affairs OfficerAward · $0 · 9,968 sh |
| Feb 13, 2026Form 4 | Onyia JudeChief Scientific OfficerAward · Restricted Stock Unit · $0 · 9,669 sh |
| Feb 13, 2026Form 4 | ABERNETHY MATTChief Financial OfficerAward · Restricted Stock Unit · $0 · 7,735 sh |
| Feb 13, 2026Form 4 | BENEVICH ERICChief Commercial OfficerAward · Restricted Stock Unit · $0 · 6,365 sh |
| Feb 13, 2026Form 4 | Keswani Sanjay ChandruChief Medical OfficerAward · Restricted Stock Unit · $0 · 6,285 sh |
| Feb 13, 2026Form 4 | Lippoldt DarinChief Legal OfficerAward · Restricted Stock Unit · $0 · 6,124 sh |
| Feb 13, 2026Form 4 | Boyer David W.Chief Corp. Affairs OfficerAward · Restricted Stock Unit · $0 · 5,479 sh |
| Feb 13, 2026Form 4 | Delaet IngridChief Regulatory OfficerAward · Restricted Stock Unit · $0 · 5,479 sh |
| Feb 13, 2026Form 4 | Onyia JudeChief Scientific OfficerExercise or conversion · $0 · 5,407 sh |
| Feb 13, 2026Form 4 | Onyia JudeChief Scientific OfficerExercise or conversion · Restricted Stock Unit · $0 · 5,407 sh |
| Feb 13, 2026Form 4 | Gano KyleChief Executive Officer · DirectorExercise or conversion · $0 · 4,807 sh |
| Feb 13, 2026Form 4 | Gano KyleChief Executive Officer · DirectorExercise or conversion · Restricted Stock Unit · $0 · 4,807 sh |
| Feb 13, 2026Form 4 | ABERNETHY MATTChief Financial OfficerExercise or conversion · $0 · 4,807 sh |
| Feb 13, 2026Form 4 | ABERNETHY MATTChief Financial OfficerExercise or conversion · Restricted Stock Unit · $0 · 4,807 sh |
| Feb 13, 2026Form 4 | Cooke JulieChief Human Resources OfficerAward · Restricted Stock Unit · $0 · 4,754 sh |
| Feb 13, 2026Form 4 | Lippoldt DarinChief Legal OfficerExercise or conversion · $0 · 4,100 sh |
| Feb 13, 2026Form 4 | Lippoldt DarinChief Legal OfficerExercise or conversion · Restricted Stock Unit · $0 · 4,100 sh |
| Feb 13, 2026Form 4 | BENEVICH ERICChief Commercial OfficerExercise or conversion · $0 · 4,044 sh |
| Feb 13, 2026Form 4 | BENEVICH ERICChief Commercial OfficerExercise or conversion · Restricted Stock Unit · $0 · 4,044 sh |
| Feb 13, 2026Form 4 | Boyer David W.Chief Corp. Affairs OfficerExercise or conversion · $0 · 3,352 sh |
| Feb 13, 2026Form 4 | Boyer David W.Chief Corp. Affairs OfficerExercise or conversion · Restricted Stock Unit · $0 · 3,352 sh |
| Feb 13, 2026Form 4 | Cooke JulieChief Human Resources OfficerExercise or conversion · $0 · 2,911 sh |
| Feb 13, 2026Form 4 | Cooke JulieChief Human Resources OfficerExercise or conversion · Restricted Stock Unit · $0 · 2,911 sh |
| Feb 13, 2026Form 4 | Delaet IngridChief Regulatory OfficerExercise or conversion · $0 · 2,760 sh |
| Feb 13, 2026Form 4 | Delaet IngridChief Regulatory OfficerExercise or conversion · Restricted Stock Unit · $0 · 2,760 sh |
| Feb 13, 2026Form 4 | Lippoldt DarinChief Legal OfficerGift · $0 · 365 sh |
| Feb 12, 2026Form 4 | Gano KyleChief Executive Officer · DirectorTax withholding · $326K · 2,648 sh |
| Feb 12, 2026Form 4 | Onyia JudeChief Scientific OfficerTax withholding · $176K · 1,426 sh |
| Feb 12, 2026Form 4 | ABERNETHY MATTChief Financial OfficerTax withholding · $142K · 1,151 sh |
| Feb 12, 2026Form 4 | BENEVICH ERICChief Commercial OfficerTax withholding · $133K · 1,082 sh |
| Feb 12, 2026Form 4 | Lippoldt DarinChief Legal OfficerTax withholding · $119K · 967 sh |
Reports and proxy statements#
Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K is described by its items. A form opens the document on EDGAR, or the filing’s index where it furnishes exhibits (an earnings release is the 8-K’s Exhibit 99.1).
2026 · 14 filings
| Filed | What it is |
|---|---|
| Sep 28, 20268-K | Directors or officers; compensation |
| Jul 31, 20268-K/A | Financial statements and exhibits |
| Jul 31, 202610-Q | Quarterly report, Q2 2026 — revenue $959.0M (+39% y/y), net income $144.4M, EPS $1.39 |
| Jul 30, 20268-K | Earnings release — EPS $2.36 vs $1.88 est. (+25.5%); revenue $959.0M (+39% y/y) 10.1% |
| May 28, 20268-K | Directors or officers; compensation; Shareholder vote results |
| May 18, 20268-K | Material definitive agreement; Completion of an acquisition or disposition; New financial obligation; Regulation FD disclosure |
| May 5, 202610-Q | Quarterly report, Q1 2026 — revenue $814.5M (+42% y/y), net income $197.9M, EPS $1.91 |
| May 5, 20268-K | Earnings release — EPS $1.41 vs $1.28 est. (+10.2%); revenue $814.5M (+42% y/y) 8.9% |
| Apr 15, 2026ARS | Annual report to shareholders |
| Apr 15, 2026DEFA14A | Additional proxy materials |
| Apr 15, 2026DEF 14A | Proxy statement |
| Apr 6, 20268-K | Material definitive agreement |
| Feb 11, 202610-K | Annual report, FY2025 — revenue $2.86B (+21% y/y), net income $478.6M, EPS $4.67 |
| Feb 11, 20268-K | Earnings release — EPS $1.43 vs $1.78 est. (−19.7%); revenue $805.5M (+28% y/y) 10.4% |
2025 · 16 filings
| Filed | What it is |
|---|---|
| Nov 24, 20258-K | Directors or officers; compensation |
| Oct 28, 202510-Q | Quarterly report, Q3 2025 — revenue $794.9M (+28% y/y), net income $209.5M, EPS $2.04 |
| Oct 28, 20258-K | Earnings release — EPS $2.04 vs $1.58 est. (+29.1%); revenue $794.9M (+28% y/y) 6.4% |
| Jul 30, 202510-Q | Quarterly report, Q2 2025 — revenue $687.5M (+16% y/y), net income $107.5M, EPS $1.06 |
| Jul 30, 20258-K | Results of operations |
| May 30, 20258-K | Directors or officers; compensation |
| May 22, 20258-K | Directors or officers; compensation; Shareholder vote results |
| May 5, 202510-Q | Quarterly report, Q1 2025 — revenue $572.6M (+11% y/y), net income $7.9M, EPS $0.08 |
| May 5, 20258-K | Results of operations |
| Apr 9, 2025ARS | Annual report to shareholders |
| Apr 9, 2025DEFA14A | Additional proxy materials |
| Apr 9, 2025DEF 14A | Proxy statement |
| Apr 4, 20258-K | Directors or officers; compensation; Regulation FD disclosure |
| Feb 10, 202510-K | Annual report, FY2024 — revenue $2.36B (+25% y/y), net income $341.3M, EPS $3.29 |
| Feb 6, 20258-K | Results of operations |
| Jan 27, 20258-K | Material definitive agreement; Regulation FD disclosure |
2024 · 17 filings
| Filed | What it is |
|---|---|
| Dec 20, 20248-K | Other events |
| Nov 1, 20248-K | Other events |
| Oct 30, 202410-Q | Quarterly report, Q3 2024 — revenue $622.1M (+25% y/y), net income $129.8M, EPS $1.24 |
| Oct 30, 20248-K | Results of operations |
| Oct 11, 20248-K | Directors or officers; compensation |
| Aug 28, 20248-K | Regulation FD disclosure; Other events |
| Aug 1, 202410-Q | Quarterly report, Q2 2024 — revenue $590.2M (+30% y/y), net income $65.0M, EPS $0.63 |
| Aug 1, 20248-K | Results of operations |
| May 28, 20248-K | Directors or officers; compensation; Charter, bylaws or fiscal-year change |
| May 23, 20248-K | Directors or officers; compensation; Shareholder vote results |
| May 1, 202410-Q | Quarterly report, Q1 2024 — revenue $515.3M (+23% y/y), net income $43.4M, EPS $0.42 |
| May 1, 20248-K | Results of operations |
| Apr 10, 2024ARS | Annual report to shareholders |
| Apr 10, 2024DEFA14A | Additional proxy materials |
| Apr 10, 2024DEF 14A | Proxy statement |
| Feb 9, 202410-K | Annual report, FY2023 — revenue $1.89B (+27% y/y), net income $249.7M, EPS $2.47 |
| Feb 7, 20248-K | Results of operations |
2023 · 24 filings — 16 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms
| Filed | What it is |
|---|---|
| Oct 31, 202310-Q | Quarterly report, Q3 2023 — revenue $498.8M (+29% y/y), net income $83.1M, EPS $0.82 |
| Aug 1, 202310-Q | Quarterly report, Q2 2023 — revenue $452.7M (+20% y/y), net income $95.5M, EPS $0.95 |
| May 3, 202310-Q | Quarterly report, Q1 2023 — revenue $420.4M (+35% y/y), net income −$76.6M, EPS −$0.79 |
| May 2, 2023DEFA14A | Additional proxy materials |
| Apr 6, 2023ARS | Annual report to shareholders |
| Apr 5, 2023DEFA14A | Additional proxy materials |
| Apr 5, 2023DEF 14A | Proxy statement |
| Feb 9, 202310-K | Annual report, FY2022 — revenue $1.49B (+31% y/y), net income $154.5M, EPS $1.56 |
16 current reports (8-K) not listed; the year is on EDGAR.
2022 · 15 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 1, 202210-Q | Quarterly report, Q3 2022 — revenue $387.9M (+31% y/y), net income $68.5M, EPS $0.69 |
| Aug 4, 202210-Q | Quarterly report, Q2 2022 — revenue $378.2M (+31% y/y), net income −$16.9M, EPS −$0.18 |
| May 4, 202210-Q | Quarterly report, Q1 2022 — revenue $310.6M (+31% y/y), net income $13.9M, EPS $0.14 |
| Apr 7, 2022DEFA14A | Additional proxy materials |
| Apr 7, 2022DEF 14A | Proxy statement |
| Feb 11, 202210-K | Annual report, FY2021 — revenue $1.13B (+8% y/y), net income $89.6M, EPS $0.92 |
9 current reports (8-K) not listed; the year is on EDGAR.
2021 · 16 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 1, 202110-Q | Quarterly report, Q3 2021 — revenue $296.0M (+15% y/y), net income $22.5M, EPS $0.23 |
| Aug 3, 202110-Q | Quarterly report, Q2 2021 — revenue $288.9M (−4% y/y), net income $42.3M, EPS $0.43 |
| May 5, 202110-Q | Quarterly report, Q1 2021 — revenue $236.6M (−0% y/y), net income $32.1M, EPS $0.33 |
| Apr 9, 2021DEFA14A | Additional proxy materials |
| Apr 9, 2021DEF 14A | Proxy statement |
| Feb 5, 202110-K | Annual report, FY2020 — revenue $1.05B (+33% y/y), net income $407.3M, EPS $4.16 |
10 current reports (8-K) not listed; the year is on EDGAR.
2020 · 21 filings — 15 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 9, 202010-Q | Quarterly report, Q3 2020 — revenue $258.5M (+16% y/y), net income −$57.6M, EPS −$0.62 |
| Aug 3, 202010-Q | Quarterly report, Q2 2020 — revenue $302.4M (+65% y/y), net income $79.6M, EPS $0.81 |
| May 6, 202010-Q | Quarterly report, Q1 2020 — revenue $237.1M (+71% y/y), net income $37.4M, EPS $0.39 |
| Apr 9, 2020DEFA14A | Additional proxy materials |
| Apr 9, 2020DEF 14A | Proxy statement |
| Feb 7, 202010-K | Annual report, FY2019 — revenue $788.1M (+75% y/y), net income $37.0M, EPS $0.39 |
15 current reports (8-K) not listed; the year is on EDGAR.
2019 · 14 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
| Filed | What it is |
|---|---|
| Nov 4, 201910-Q | Quarterly report, Q3 2019 — revenue $222.1M (+46% y/y), net income $53.8M, EPS $0.56 |
| Jul 29, 201910-Q | Quarterly report, Q2 2019 — revenue $183.5M (+89% y/y), net income $51.3M, EPS $0.54 |
| Apr 29, 201910-Q | Quarterly report, Q1 2019 — revenue $138.4M (+95% y/y), net income −$102.1M, EPS −$1.12 |
| Apr 17, 2019DEF 14A | Proxy statement |
| Feb 8, 201910-K | Annual report, FY2018 — revenue $451.2M (+179% y/y), net income $21.1M, EPS $0.22 |
9 current reports (8-K) not listed; the year is on EDGAR.
2018 · 18 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 5, 201810-Q | Quarterly report, Q3 2018 — revenue $151.8M (+150% y/y), net income $50.8M, EPS $0.52 |
| Jul 31, 201810-Q | Quarterly report, Q2 2018 — revenue $96.9M (+1430% y/y), net income −$5.9M, EPS −$0.07 |
| Apr 30, 201810-Q | Quarterly report, Q1 2018 — revenue $71.1M, net income −$41.8M, EPS −$0.47 |
| Apr 4, 2018DEFA14A | Additional proxy materials |
| Apr 4, 2018DEF 14A | Proxy statement |
| Feb 13, 201810-K | Annual report, FY2017 — revenue $161.6M (+978% y/y), net income −$142.5M, EPS −$1.62 |
12 current reports (8-K) not listed; the year is on EDGAR.
2017 · 25 filings — 19 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 1, 201710-Q | Quarterly report, Q3 2017 — revenue $60.8M, net income −$11.1M, EPS −$0.13 |
| Aug 3, 201710-Q | Quarterly report, Q2 2017 — revenue $6.3M, net income −$60.0M, EPS −$0.68 |
| May 9, 201710-Q | Quarterly report, Q1 2017 — revenue $0 (−100% y/y), net income −$78.3M, EPS −$0.90 |
| Apr 21, 2017DEF 14A | Proxy statement |
| Feb 14, 201710-K | Annual report, FY2016 — revenue $15.0M (−24% y/y), net income −$141.1M, EPS −$1.63 |
20 current reports (8-K) not listed; the year is on EDGAR.
2016 · 16 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2015 · 17 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2014 · 13 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2013 · 11 filings — 6 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2012 · 15 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2011 · 14 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2010 · 17 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2009 · 14 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2008 · 14 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2007 · 21 filings — 15 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2006 · 27 filings — 21 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2005 · 26 filings — 20 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2004 · 15 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2003 · 12 filings — 7 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2002 · 8 filings — 3 × 10-Q, 3 × 8-K, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2001 · 10 filings — 5 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2000 · 9 filings — 3 × 10-Q, 3 × 8-K, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
1999 · 5 filings — 3 × 10-Q, 1 × 10-K, 1 × DEF 14A
Counted, not listed; the year is on EDGAR.
1998 · 6 filings — 3 × 10-Q, 1 × 10-K, 1 × 8-K and 1 other form
Counted, not listed; the year is on EDGAR.
1997 · 8 filings — 3 × 10-Q, 1 × 10-K405, 1 × 10-K405/A and 3 other forms
Counted, not listed; the year is on EDGAR.
1996 · 2 filings — 2 × 10-Q
Counted, not listed; the year is on EDGAR.
Insider, ownership and other filings#
Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.
2026 · 102 filings — 72 × 4, 18 × 144, 3 × SC TO-C and 7 other forms
| Filed | What it is |
|---|---|
| Sep 15, 20264 | Insider transaction (Form 4) |
| Sep 15, 20264 | Insider transaction (Form 4) |
| Sep 15, 20264 | Insider transaction (Form 4) |
| Sep 15, 20264 | Insider transaction (Form 4) |
| Sep 15, 20264 | Insider transaction (Form 4) |
| Sep 15, 20264 | Insider transaction (Form 4) |
| Sep 15, 20264 | Insider transaction (Form 4) |
| Sep 15, 20264 | Insider transaction (Form 4) |
| Sep 15, 20264 | Insider transaction (Form 4) |
| Sep 15, 20264 | Insider transaction (Form 4) |
| Sep 14, 2026144 | Notice of proposed sale (Form 144) |
| Sep 14, 2026144 | Notice of proposed sale (Form 144) |
| Sep 10, 20264 | Insider transaction (Form 4) |
| Sep 9, 2026144 | Notice of proposed sale (Form 144) |
| Sep 3, 20264 | Insider transaction (Form 4) |
| Aug 5, 20264 | Insider transaction (Form 4) |
| Jul 31, 2026S-8 | Employee stock plan registration |
| Jul 30, 20264 | Insider transaction (Form 4) |
| Jul 13, 20264 | Insider transaction (Form 4) |
| Jul 13, 20264 | Insider transaction (Form 4) |
| Jul 10, 2026144 | Notice of proposed sale (Form 144) |
| Jul 9, 20264 | Insider transaction (Form 4) |
| Jul 9, 2026144 | Notice of proposed sale (Form 144) |
| Jul 7, 2026144 | Notice of proposed sale (Form 144) |
| Jun 30, 20264 | Insider transaction (Form 4) |
The newest 25 of 102 shown; the full year is on EDGAR.
2025 · 134 filings — 61 × 4, 56 × 144, 12 × S-8 POS and 4 other forms
| Filed | What it is |
|---|---|
| Dec 17, 20254 | Insider transaction (Form 4) |
| Dec 15, 2025144 | Notice of proposed sale (Form 144) |
| Dec 10, 20254 | Insider transaction (Form 4) |
| Dec 8, 2025144 | Notice of proposed sale (Form 144) |
| Dec 4, 20254 | Insider transaction (Form 4) |
| Dec 3, 2025144 | Notice of proposed sale (Form 144) |
| Dec 2, 20254 | Insider transaction (Form 4) |
| Dec 2, 20254 | Insider transaction (Form 4) |
| Nov 28, 2025144 | Notice of proposed sale (Form 144) |
| Nov 26, 20254 | Insider transaction (Form 4) |
| Nov 25, 2025144 | Notice of proposed sale (Form 144) |
| Nov 6, 20254 | Insider transaction (Form 4) |
| Nov 5, 2025144 | Notice of proposed sale (Form 144) |
| Nov 5, 2025144 | Notice of proposed sale (Form 144) |
| Nov 4, 20254 | Insider transaction (Form 4) |
| Sep 4, 20254 | Insider transaction (Form 4) |
| Sep 3, 20254 | Insider transaction (Form 4) |
| Aug 11, 20254 | Insider transaction (Form 4) |
| Aug 7, 20254 | Insider transaction (Form 4) |
| Aug 7, 2025144 | Notice of proposed sale (Form 144) |
| Jul 11, 20254 | Insider transaction (Form 4) |
| Jul 11, 20254 | Insider transaction (Form 4) |
| Jul 10, 2025144 | Notice of proposed sale (Form 144) |
| Jul 7, 20254 | Insider transaction (Form 4) |
| Jul 2, 2025144 | Notice of proposed sale (Form 144) |
The newest 25 of 134 shown; the full year is on EDGAR.
2024 · 161 filings — 89 × 4, 68 × 144, 2 × SC 13G/A and 2 other forms
| Filed | What it is |
|---|---|
| Dec 31, 2024144 | Notice of proposed sale (Form 144) |
| Dec 19, 20244 | Insider transaction (Form 4) |
| Dec 19, 20244 | Insider transaction (Form 4) |
| Dec 17, 2024144 | Notice of proposed sale (Form 144) |
| Dec 3, 20244 | Insider transaction (Form 4) |
| Nov 29, 2024144 | Notice of proposed sale (Form 144) |
| Nov 12, 20244 | Insider transaction (Form 4) |
| Nov 7, 20244 | Insider transaction (Form 4) |
| Nov 1, 20244 | Insider transaction (Form 4) |
| Oct 17, 2024SC 13G | Passive holder above 5% (Schedule 13G) |
| Oct 7, 20244 | Insider transaction (Form 4) |
| Sep 17, 20244 | Insider transaction (Form 4) |
| Sep 13, 2024144 | Notice of proposed sale (Form 144) |
| Aug 16, 20244 | Insider transaction (Form 4) |
| Aug 15, 20244 | Insider transaction (Form 4) |
| Aug 15, 20244 | Insider transaction (Form 4) |
| Aug 15, 20244 | Insider transaction (Form 4) |
| Aug 8, 20244 | Insider transaction (Form 4) |
| Aug 5, 20244 | Insider transaction (Form 4) |
| Aug 5, 20244 | Insider transaction (Form 4) |
| Aug 1, 2024S-8 | Employee stock plan registration |
| Jul 18, 20244 | Insider transaction (Form 4) |
| Jul 18, 20244 | Insider transaction (Form 4) |
| Jul 18, 20244 | Insider transaction (Form 4) |
| Jul 18, 20244 | Insider transaction (Form 4) |
The newest 25 of 161 shown; the full year is on EDGAR.
2023 · 115 filings — 76 × 4, 27 × 144, 5 × 4/A and 4 other forms
Counted, not listed; the year is on EDGAR.
2022 · 62 filings — 54 × 4, 5 × SC 13G/A, 1 × 3 and 2 other forms
Counted, not listed; the year is on EDGAR.
2021 · 62 filings — 35 × 4, 10 × 4/A, 9 × SC 13G/A and 4 other forms
Counted, not listed; the year is on EDGAR.
2020 · 84 filings — 74 × 4, 5 × SC 13G/A, 2 × SC 13G and 3 other forms
Counted, not listed; the year is on EDGAR.
2019 · 68 filings — 53 × 4, 7 × SC 13G/A, 3 × 3 and 3 other forms
Counted, not listed; the year is on EDGAR.
2018 · 68 filings — 56 × 4, 5 × SC 13G/A, 3 × CT ORDER and 3 other forms
Counted, not listed; the year is on EDGAR.
2017 · 87 filings — 76 × 4, 4 × SC 13G/A, 2 × 3 and 4 other forms
Counted, not listed; the year is on EDGAR.
2016 · 63 filings — 51 × 4, 5 × 4/A, 4 × SC 13G/A and 3 other forms
Counted, not listed; the year is on EDGAR.
2015 · 87 filings — 72 × 4, 4 × SC 13G/A, 3 × 3 and 6 other forms
Counted, not listed; the year is on EDGAR.
2014 · 67 filings — 54 × 4, 6 × SC 13G/A, 2 × 3 and 3 other forms
Counted, not listed; the year is on EDGAR.
2013 · 52 filings — 35 × 4, 5 × SC 13G/A, 4 × SC 13G and 5 other forms
Counted, not listed; the year is on EDGAR.
2012 · 25 filings — 14 × 4, 5 × SC 13G/A, 2 × 424B5 and 4 other forms
Counted, not listed; the year is on EDGAR.
2011 · 32 filings — 22 × 4, 6 × SC 13G/A, 2 × CT ORDER and 2 other forms
Counted, not listed; the year is on EDGAR.
2010 · 59 filings — 31 × 4, 5 × SC 13G/A, 4 × SC 13G and 10 other forms
Counted, not listed; the year is on EDGAR.
2009 · 50 filings — 36 × 4, 5 × SC 13G/A, 2 × CT ORDER and 7 other forms
Counted, not listed; the year is on EDGAR.
2008 · 56 filings — 42 × 4, 7 × SC 13G/A, 3 × 3 and 3 other forms
Counted, not listed; the year is on EDGAR.
2007 · 39 filings — 22 × 4, 6 × SC 13G/A, 3 × SC 13G and 8 other forms
Counted, not listed; the year is on EDGAR.
2006 · 32 filings — 16 × 4, 7 × SC 13G/A, 4 × SC 13G and 4 other forms
Counted, not listed; the year is on EDGAR.
2005 · 47 filings — 38 × 4, 3 × 3, 3 × SC 13G/A and 2 other forms
Counted, not listed; the year is on EDGAR.
2004 · 50 filings — 41 × 4, 4 × SC 13G/A, 2 × 3 and 3 other forms
Counted, not listed; the year is on EDGAR.
2003 · 62 filings — 45 × 4, 6 × SC 13G/A, 3 × 3 and 7 other forms
Counted, not listed; the year is on EDGAR.
2002 · 10 filings — 5 × SC 13G/A, 2 × 4, 2 × S-8 and 1 other form
Counted, not listed; the year is on EDGAR.
2001 · 12 filings — 4 × SC 13G, 3 × SC 13G/A, 2 × 424B5 and 2 other forms
Counted, not listed; the year is on EDGAR.
2000 · 10 filings — 3 × S-3/A, 2 × S-3, 2 × SC 13G/A and 3 other forms
Counted, not listed; the year is on EDGAR.
1999 · 2 filings — 1 × S-8, 1 × SC 13G/A
Counted, not listed; the year is on EDGAR.
1998 · 6 filings — 2 × SC 13G/A, 1 × NT 10-K, 1 × S-8 and 2 other forms
Counted, not listed; the year is on EDGAR.
1997 · 4 filings — 2 × SC 13G, 1 × 8-A12G, 1 × S-8
Counted, not listed; the year is on EDGAR.
1996 · 7 filings — 3 × S-1/A, 1 × 424B1, 1 × S-1MEF and 2 other forms
Counted, not listed; the year is on EDGAR.
About this data
Neurocrine Biosciences Inc. (NBIX) has 2,175 filings on EDGAR going back to 1996: 33 annual reports, 92 quarterly reports and 288 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 11, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Sep 28, 2026, covered directors or officers; compensation. Over the last 13 months insiders sold $68.1M in 22 sales and bought nothing on the open market; 203 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.
Every row is a filing EDGAR lists for the registrants that have been Neurocrine Biosciences Inc., read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.
FAQ#
- Where can I read NBIX's latest 10-K?
- NBIX's latest annual report, a 10-K, was filed on Feb 11, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
- When did NBIX last file an 8-K?
- On Sep 28, 2026: directors or officers; compensation. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Jul 30, 2026.
- Are NBIX insiders buying or selling?
- Over the last 13 months insiders sold $68.1M in 22 sales and bought nothing on the open market; 203 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: ABERNETHY MATT (Chief Financial Officer) sold 2,311 shares on Sep 14, 2026 for $363K, under a 10b5-1 plan. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
- How many SEC filings has NBIX made?
- 2,175 filings are on EDGAR under the registrant records that have been Neurocrine Biosciences Inc., going back to 1996; 1,399 of them are insider ownership forms (Forms 3, 4, 5 and 144).